CD38 is a membrane protein consisting of a catalytic carboxyl domain (C), a single stretch of trans-membrane segment and a short amino (N) tail of 21 residues. It has long been thought to have a type II membrane orientation with the catalytic C-domain facing outside. It has never been
fully understood how an ecto-enzyme can gain access to its intracellular substrates, NAD and NADP, and produce the signaling messengers, cADPR and NAADP that target intracellular Ca2+ stores. A vesicular mechanism has been proposed, positing that CD38 can be endocytosed, together
with transport proteins, into endo-lysosomes. These proteins, such as connexin 43 and nucleoside transporters, can then mediate the influx of substrates for CD38 and efflux of the messenger products from the endo-lysosomes. Recently, we have shown that CD38, in fact, exists naturally in two
opposite membrane orientations in human peripheral blood mononuclear cells, promyelocytic leukemic HL60 cells and the monocytic U937 cells, not only in the expected type II orientation but also in the opposite type III orientation, with the catalytic C-domain facing the cytosol (Science Signaling
5, ra67 (2012)). The type III CD38 is fully active in producing intracellular cADPR. This presentation will summarize and update the current status of the topological aspects of CD38-signaling mechanism.